Members Listed by Alphabetical Order
Members of CNS & Women's Health fall into one or more of the following categories: (1) investigators at UCLA, VAGLAHS, Ohio State University, University of Pittsburgh, or other campus who are principal or co-principal investigators with peer-reviewed, competitive funding for research in neurovisceral sciences, gastrointestinal disorders, urological disorders, and stress neurobiology, and stress-immune system interactions, particularly related to sex-based differences and whose research directly impacts the goals of the Center; (2) division chiefs in gastroenterology, urology, obstetrics and gynecology, and psychiatry; (3) directors or co-directors of programs or cores, or individuals who have relevant roles within the Center and (4) clinicians who have made significant contributions to the main subject matters of the Center.
Associate Members are investigators who work closely with one or more CNS & Women's Health members and who have major responsibility for design, conduct, and reporting of research studies, but who have not yet reached independence in funding; and individuals who contribute greatly on an ongoing basis to research projects at CNS & Women's Health. They are reviewed periodically for advancement to full membership.
If you are interested
in becoming a member, please contact Million Mulugeta, DVM, PhD at mmuluget@ucla.edu.
Click on each member's name to see contact information, research description, and their Biosketch. Biosketches are in PDF format and will require Adobe Acrobat Reader to view. Click here to get the free Acrobat Reader.
Members
|
Name
|
Research
Interest
|
| Deborah Ackerman, PhD | Clinical: Alternative medicine, Clinical trials design/analysis, Epidemiology, Mental health, Outcomes research |
| David Adelson, PhD | Preclinical: |
| Jeffrey Alger, PhD | Pathophysiological imaging using a novel forms of magnetic resonance imaging and magnetic resonance spectroscopy |
| Peter Anton, MD | Clinical: inflammatory bowel diseases and HIV-related enteric disorders. Preclinical: mucosal inflammation and immune responses, HIV vaccines and microbicides |
| Arthur Arnold, PhD | Preclinical: Sex differences in the brain, neuroendocrinology, evolution and function of the sex chromosomes |
| Mark Barad, MD, PhD | Clinical: Learning and memory; extinction of conditioned fear; mouse models of human anxiety disorders |
| Carol Bennett, MD | Clinical: Neurourology, spinal cord injury |
| Steve Berman, PhD | Clinical: Alcohol and drug abuse vulnerability; brain imaging |
| Lori Birder, PhD | Preclinical: Urinary bladder Urothelium; feline interstitial cystitis; "neuronal-like" properties of urothelial cells. |
| Roger Bolus, PhD | Clinical: Research Design, Statistical & Psychometric Analysis, Survey Development, Database Design |
| Susan Bookheimer, PhD | Preclinical: Functional neuroanatomy of language and memory systems Clinical : Functional imaging for pre-surgical planning; imaging in neurologic and psychiatric disorders; structural and functional imaging in Alzheimer's Disease |
| Sylvie Bradesi, PhD | Preclinical: stress modulation of visceral pain, animal models |
| Arthur Brody, MD | |
| Tony Buffington, DVM, PhD | Preclinical: interstitial cystitis, neuroendocrinology, animal models |
| Nigel Bunnett, MD | Preclinical: intracellular signalling, neuropeptides, proteases, G-protein coupled receptors, inflammatory diseases, pain transmission |
| Victor Chaban, PhD | Preclinical: euroendocrinology, steroid modulation of nociception |
| Lin Chang, MD (Co-Director) | Clinical:chronic pain disorders, neuroendocrine and neuroimmune brain-gut interactions, and gender differences |
| Gautam Chaudhuri, MD, PhD |
nitric oxide, estrogens, atherosclerosis, breast cancer |
| Francesco Chiappelli, PhD | evidence-based research; psychoneuroimmunology |
| Mark Cohen, PhD | Clinical: Technology and applications of functional magnetic resonance imaging |
| Ian Cook, MD | Clinical: depression, placebo, dementia, EEG, MRI, brain function, yoga, CAM, clinical trials |
| Michelle Craske, PhD | Clinical: psychophysiological and cognitive risk factors, and cognitive and behavioral treatment for fear, anxiety and related disorders |
| Christine Dunkel Schetter, PhD | Stress and coping processes; social support; biopsychosocial processes in pregnancy, preterm delivery, low birth weight and other maternal/infant outcomes; and women's reproductive health. |
| Chris Evans, PhD | Preclinical: Neurobiology of opioids |
| Michael Fanselow, PhD | Preclinical: Learning, memory, emotion |
| Fawzy Fawzy, MD | |
| Vay Liang W. Go, MD | Clinical: Translational research on brain-islet-gut function in diet and cancer |
| Michael Goldstein, PhD | Clinical: Complementary and alternative medicine, self-help, self-care, epidemiology |
| Philip Hanno, MD | Clinical: Interstitial cystitis, pelvic pain |
| Ronald Harper, PhD | Sleep, disordered breathing, heart failure, blood pressure control |
| Daniel Holschneider, MD | Preclinical: Functional neuroimaging in freely moving animals, Behavior and physiologic function in animal models |
| Jennifer Labus, PhD | Clinical: altered central and autonomic nervous system processes in IBS, neural network analyses |
| Robert Lemelson, PhD | Transcultural psychiatry, psychological anthropology, Indonesia |
| Andrew Leuchter, MD | |
| Matthew Lieberman, PhD | Clinical: Social cognitive neuroscience, Neural correlates of placebo effects, Neural correlates of affect regulation, Overlap between social pain and physical pain |
| Edythe London, PhD | Cinical: Studies of addictive and other neuropsychiatric disorders using neuroimaging techniques |
| Sheng-Xing Ma, MD, PhD | |
| Mark Mandelkern, MD, PhD | Preclinical and clinical: Imaging with radiological, nuclear, optical and electrophysiological techniques in humans and animals |
| Juan-Carlos Marvizon, PhD | Preclinical: Neurophysiology of pain and analgesia investigating cellular and molecular mechanisms that mediate central sensitization in the spinal cord |
| Emeran Mayer, MD (Director) | Preclinical and Clinical: Neurobiology of visceral pain, stress and brain-gut interactions |
| John McDonald, MD | |
| James McRoberts, PhD | Preclinical: Molecular neurobiology of visceral pain, Neuroendocrine and immune interactions |
| Paul Micevych, PhD | Preclinical: reproductive neuroendocrinology, steroid modulation of visceral nociception. |
| Holly Middlekauff, MD | |
| Million Mulugeta, DVM, PhD | Preclinical: Neurobiology of stress-related gut motility and visceral pain |
| Cynthia Myers, PhD | Clinical: Sex and gender differences, pain, massage, relaxation, complementary and alternative medicine |
| Bruce Naliboff, PhD (Co-Director) | Clinical: |
| Gordon Ohning, MD, PhD | |
| Edward Ornitz, MD | Clinical: Clinical neurophysiology, focusing on startle modulation in developmental disorders and childhood psychophysiology |
| Joseph Pisegna, MD | |
| Andrea Rapkin, MD | Clinical: chronic pelvic pain, multidisciplinary, vulvadynia, endometriosis |
| Shlomo Raz, MD | |
| Larissa Rodriguez, MD | |
| Michael Ross, MD, MPH | |
| David Shapiro, PhD | Psychosocial factors affecting blood pressure in everyday life and risk for hypertension; Effects of mood, social stress, coping styles, family history, and gender; Yoga as a complementary treatment of depression |
| Brennan Spiegel, MD, MSHS | Clinical: Cost-effectiveness analysis and medical decision-making; predictors of health-related quality of life in irritable bowel syndrome and dyspepsia; role of the physician-patient relationship in IBS |
| Igor Spigelman, PhD |
Preclinical: pharmacology of chronic pain syndromes, alcohol abuse, epilepsy and traumatic brain injury. |
| Catia Sternini, MD | Preclinical: Neurogastroenterology |
| Yvette Taché, PhD (Co-Director) | Preclinical: Brain-gut interactions |
| Shelley Taylor, PhD | Clinical: Stress, HIV, coping, gender |
| Kirsten Tillisch, MD | Clinical: functional gastrointestinal disorders, mind-body interactions |
| S. Vincent Wu, PhD | Preclinical |
| Hong Yang, MD, PhD | Preclinical: Regulation of medullary autonomic regulatory pathways by circulating hormones |
Associate Members
|
Name
|
Research
Interest
|
| Yasutada Akiba, MD, PhD | Preclinical: In vivo fluorescence microscopy, mucosal defenses, chemo-sensing in the gut |
| Joshua Bueller | |
| Naomi Eisenberger, PhD | Clinical: pain, stress, emotion, neuroimaging, social rejection |
| Helena Ennes, MD | Preclinical: Molecular neurobiology of visceral pain, stress and brain-gut interactions, neuroendocrine and immune interactions |
| Leah FitzGerald, RN, PhD | Clinical: |
| Michael Fresé, PhD | |
| Caroline Lubick Goldzweig, MD | Clinical: Women's health, quality improvement, quality of care |
| Marion Ho, MD | |
| Behnaz Jalali, MD | |
| Johanna Jarcho | |
| Lisa Kilpatrick, PhD | |
| Hovsep Kosoyan, PhD | Preclinical: |
| Muriel Larauche, PhD | Pre-clinical |
| Jichang Li, MD, PhD | Preclinical:Molecular and electrophysiological study of ion channels, characterization of NMDA receptors in rat DRG neurons and demonstration of their roles in visceral pain and hyperalgesia |
| Brandall Suyenobu, PhD | Clinical: brain imaging, cognitive/somatic interactions, cognitive neuropsychology |
| Steven Tan, MD, MTOM | Clinical: traditional chinese medicine, complementary and alternative medicine (CAM), integrative medicine, mind/body medicine, acupuncture, herbs, functional syndromes, stress medicine |
| Lixin Wang, MD, PhD | Preclinical: Brain-gut interaction in regulations of responses to stress and of feeding behavior |